期刊文献+

IL-22对大鼠肝脏缺血再灌注损伤的影响及相关机制 被引量:2

Effects of IL-22 on hepatic ischemia-reperfusion injury and related mechanism in SD rats
原文传递
导出
摘要 目的探究白细胞介素22(IL-22)对大鼠肝脏缺血再灌注损伤(IRI)的作用及相关机制。方法将18只健康雄性无特定病原体SD大鼠(7~8周龄,250 g左右)随机分为三组:假手术组(Sham)、肝脏缺血再灌注组(IRI)、IL-22预处理组(IL-22+IRI)。构建70%大鼠肝脏IRI模型,IL-22+IRI组术前1 h腹腔注射重组IL-22(50 mg/kg),Sham组、IRI组术前1 h注射等体积生理盐水。缺血1 h再灌注6 h后取血及肝脏组织检测血清天冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)水平,检测肝组织超氧化物歧化酶(SOD)、丙二醛(MDA)水平,Western blot法检测信号转导和转录激活因子3(STAT3)、磷酸化STAT3(p-STAT3)、核因子E2相关因子2(Nrf2)和血红素加氧酶1(HO-1)的表达。结果与Sham组比较,IRI组和IL-22+IRI组血清AST[(1923.50±92.63)U/L、(1004.25±65.05)U/L]和ALT[(1172.51±180.31)U/L、(583.50±164.75)U/L]水平升高(AST:F=293.62;ALT:F=30.33),肝组织MDA[(1.72±0.12)μmol/mg、(0.98±0.05)μmol/mg]水平较Sham组(0.58±0.14)μmol/mg升高(F=186.73),p-STAT3、Nrf2、HO-1表达增加,IRI组SOD水平(28.51±3.85)U/mg较Sham组(70.25±5.64)U/mg降低(F=203.41),差异均有统计学意义(均P<0.05);与IRI组相比,IL-22+IRI组大鼠血清AST和ALT水平下降,肝组织SOD活性增加,MDA水平下降,p-STAT3、Nrf2、HO-1表达增加,差异均有统计学意义(均P<0.05)。结论IL-22可减轻大鼠肝脏IRI,其机制可能与激活STAT3以及Nrf2/HO-1信号通路和抑制氧化应激有关。 Objective To investigate the protective effect of IL-22 on rat liver ischemia reperfusion injury(IRI)and the potential mechanisms.Methods Eighteen male specific pathogen free SD rats(7-8 weeks,about 250g)were randomly divided into three groups:Sham group(Sham),hepatic ischemia reperfusion(IRI)and IL-22 preconditioning group(IL-22+IRI),respectively.The liver IRI model of 70%rats was established.The IL-22+IRI group was intraperitoneally injected with rcIL-22(50 mg/kg)1 hour before surgery,and the Sham group and IRI group were injected with the same dose of normal saline 1 hour before surgery.After 1 h ischemia and 6 h reperfusion,blood was collected from the abdominal aorta,then liver tissue,serum aspartate transaminase(AST)and alanine aminotransfease(ALT)levels were measured.The levels of superoxide dismutase(SOD)and malondialdehyde(MDA)in liver tissue were detected.The expression of signal transducer and activator of transcription 3(STAT3),p-STAT3,nuclear factor erythorid-2 related factor 2(Nrf2)and heme oxygenase 1(HO-1)were detected by Western blot.Results Compared with Sham group,serum AST[(1923.50±92.63)U/L,(1004.25±65.05)U/L]and ALT[(1172.51±180.31)U/L,(583.50±164.75)U/L]levels were increased in IRI group and IL-22+IRI group(AST:F=293.62;ALT:F=30.33,P<0.05).The levels of MDA in IRI group and IL-22+IRI group[(1.72±0.12)μmol/mg,(0.98±0.05)μmol/mg]in liver tissue were higher than those in Sham group(0.58±0.14)μmol/mg protein(F=186.73,P<0.05),and the expression of p-STAT3,Nrf2 and HO-1 was increased.SOD level in IRI group(28.51±3.85)U/mg was lower than that in Sham group(70.25±5.64)U/mg protein(F=203.41,P<0.05).Compared with IRI group,serum AST and ALT levels in IL-22+IRI group were decreased,SOD activity in liver tissue was increased,MDA level was decreased,and p-STAT3,Nrf2 and HO-1 expression was increased(all P<0.05).Conclusion IL-22 could alleviate liver IRI in rats,and the mechanism may be related to the activation of STAT3 and Nrf2/HO-1 signaling pathway and anti-oxidative stress.
作者 吴昊 张赛 王昊 张智鑫 张锦锐 白易 张雅敏 Wu Hao;Zhang Sai;Wang Hao;Zhang Zhixin;Zhang Jinrui;Bai Yi;Zhang Yamin(The First Central Clinical School,Tianjin Medical University,Tianjin 300070,China;School of Medicine,NanKai University,Tianjin 300192,China;Department of Hepatobiliary Surgery,Tianjin First Central Hospital,Tianjin 300192,China)
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2022年第7期542-546,共5页 Chinese Journal of Hepatobiliary Surgery
基金 天津市科技计划项目(19ZXDBSY00010) 天津市自然科学基金(20JCYBJC01310)。
关键词 再灌注损伤 白细胞介素-22 Liver Reperfusion injury Interleukin-22
  • 相关文献

参考文献5

二级参考文献35

  • 1Wei Gao,Yu-Chen Fan,Ji-Yuan Zhang,Ming-Hua Zheng.Emerging Role of Interleukin 22 in Hepatitis B Virus Infection: a Double-edged Sword[J].Journal of Clinical and Translational Hepatology,2013,1(2):103-108. 被引量:4
  • 2Dumoutier L, Louahed J, Renauld JC. Cloning and characterizationof IL-10-related T cell-derived inducible factor (IL-TIF),a novel cytokine structurally related to IL-10 and inducible byIL-9. J Immunol 2000; 164: 1814-1819 [PMID: 10657629 DOI:10.4049/jimmunol.164.4.1814].
  • 3Ki SH, Park O, Zheng M, Morales-Ibanez O, Kolls JK, Bataller R,Gao B. Interleukin-22 treatment ameliorates alcoholic liver injuryin a murine model of chronic-binge ethanol feeding: role of signaltransducer and activator of transcription 3. Hepatology 2010; 52:1291-1300 [PMID: 20842630 DOI: 10.1002/hep.23837].
  • 4Yang L, Zhang Y, Wang L, Fan F, Zhu L, Li Z, Ruan X, HuangH, Wang Z, Huang Z, Huang Y, Yan X, Chen Y. Amelioration ofhigh fat diet induced liver lipogenesis and hepatic steatosis byinterleukin-22. J Hepatol 2010; 53: 339-347 [PMID: 20452699DOI: 10.1016/j.jhep.2010.03.004].
  • 5Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ,Karow M, Flavell RA. Interleukin-22 but not interleukin-17provides protection to hepatocytes during acute liver inflammation.Immunity 2007; 27: 647-659 [PMID: 17919941 DOI: 10.1016/j.immuni.2007.07.023].
  • 6Radaeva S, Sun R, Pan HN, Hong F, Gao B. Interleukin 22 (IL-22)plays a protective role in T cell-mediated murine hepatitis: IL-22 isa survival factor for hepatocytes via STAT3 activation. Hepatology2004; 39: 1332-1342 [PMID: 15122762 DOI: 10.1002/hep.20184].
  • 7Ren X, Hu B, Colletti LM. IL-22 is involved in liver regenerationafter hepatectomy. Am J Physiol Gastrointest Liver Physiol 2010;298: G74-G80 [PMID: 19875704 DOI: 10.1152/ajpgi.00075.2009].
  • 8Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC,Morel F. IL-22 inhibits epidermal differentiation and inducesproinflammatory gene expression and migration of humankeratinocytes. J Immunol 2005; 174: 3695-3702 [PMID: 15749908DOI: 10.4049/jimmuol.174.6.3695].
  • 9Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, OtteJM, Diepolder H, Marquardt A, Jagla W, Popp A, Leclair S,Herrmann K, Seiderer J, Ochsenkühn T, G-ke B, AuernhammerCJ, Dambacher J. IL-22 is increased in active Crohn's disease andpromotes proinflammatory gene expression and intestinal epithelialcell migration. Am J Physiol Gastrointest Liver Physiol 2006; 290:G827-G838 [PMID: 16537974 DOI: 10.1152/ajpgi.00513.2005].
  • 10Chung Y, Yang X, Chang SH, Ma L, Tian Q, Dong C. Expressionand regulation of IL-22 in the IL-17-producing CD4+ Tlymphocytes. Cell Res 2006; 16: 902-907 [PMID: 17088898 DOI:10.1038/sj.cr.7310106].

共引文献22

同被引文献5

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部